nodes	percent_of_prediction	percent_of_DWPC	metapath
Rabeprazole—ABCG2—Vemurafenib—melanoma	0.148	0.2	CbGbCtD
Rabeprazole—CYP1A1—Dacarbazine—melanoma	0.105	0.142	CbGbCtD
Rabeprazole—ABCG2—Dactinomycin—melanoma	0.0984	0.133	CbGbCtD
Rabeprazole—CYP1A2—Carmustine—melanoma	0.0772	0.105	CbGbCtD
Rabeprazole—CYP1A2—Vemurafenib—melanoma	0.0611	0.0826	CbGbCtD
Rabeprazole—CYP3A4—Temozolomide—melanoma	0.0584	0.079	CbGbCtD
Rabeprazole—ABCG2—Docetaxel—melanoma	0.0508	0.0688	CbGbCtD
Rabeprazole—CYP2D6—Vemurafenib—melanoma	0.0503	0.0681	CbGbCtD
Rabeprazole—CYP1A2—Dacarbazine—melanoma	0.0468	0.0633	CbGbCtD
Rabeprazole—CYP3A4—Vemurafenib—melanoma	0.032	0.0433	CbGbCtD
Rabeprazole—CYP3A4—Docetaxel—melanoma	0.011	0.0149	CbGbCtD
Rabeprazole—Omeprazole—CYP1B1—melanoma	0.00163	0.355	CrCbGaD
Rabeprazole—Lansoprazole—CYP1B1—melanoma	0.00149	0.325	CrCbGaD
Rabeprazole—Pantoprazole—ABCB1—melanoma	0.000575	0.125	CrCbGaD
Rabeprazole—Omeprazole—ABCB1—melanoma	0.000469	0.102	CrCbGaD
Rabeprazole—Lansoprazole—ABCB1—melanoma	0.000429	0.0932	CrCbGaD
Rabeprazole—Pruritus—Vemurafenib—melanoma	0.000342	0.00164	CcSEcCtD
Rabeprazole—Urethral disorder—Temozolomide—melanoma	0.000341	0.00163	CcSEcCtD
Rabeprazole—Alopecia—Dactinomycin—melanoma	0.00034	0.00163	CcSEcCtD
Rabeprazole—Eye disorder—Carmustine—melanoma	0.000336	0.00161	CcSEcCtD
Rabeprazole—Hyponatraemia—Docetaxel—melanoma	0.000336	0.00161	CcSEcCtD
Rabeprazole—Visual impairment—Temozolomide—melanoma	0.000335	0.00161	CcSEcCtD
Rabeprazole—Erythema—Dactinomycin—melanoma	0.000335	0.0016	CcSEcCtD
Rabeprazole—Gastrointestinal haemorrhage—Docetaxel—melanoma	0.000334	0.0016	CcSEcCtD
Rabeprazole—Ill-defined disorder—Bleomycin—melanoma	0.000333	0.0016	CcSEcCtD
Rabeprazole—Anaemia—Bleomycin—melanoma	0.000332	0.00159	CcSEcCtD
Rabeprazole—Diarrhoea—Vemurafenib—melanoma	0.000331	0.00159	CcSEcCtD
Rabeprazole—Migraine—Docetaxel—melanoma	0.000329	0.00158	CcSEcCtD
Rabeprazole—Erythema multiforme—Temozolomide—melanoma	0.000329	0.00158	CcSEcCtD
Rabeprazole—Eye disorder—Temozolomide—melanoma	0.000325	0.00156	CcSEcCtD
Rabeprazole—Tinnitus—Temozolomide—melanoma	0.000324	0.00155	CcSEcCtD
Rabeprazole—Malaise—Bleomycin—melanoma	0.000324	0.00155	CcSEcCtD
Rabeprazole—Arrhythmia—Carmustine—melanoma	0.000322	0.00154	CcSEcCtD
Rabeprazole—Leukopenia—Bleomycin—melanoma	0.000321	0.00154	CcSEcCtD
Rabeprazole—Dizziness—Vemurafenib—melanoma	0.00032	0.00153	CcSEcCtD
Rabeprazole—Alopecia—Carmustine—melanoma	0.000318	0.00152	CcSEcCtD
Rabeprazole—Angiopathy—Temozolomide—melanoma	0.000316	0.00151	CcSEcCtD
Rabeprazole—Malnutrition—Carmustine—melanoma	0.000313	0.0015	CcSEcCtD
Rabeprazole—Erythema—Carmustine—melanoma	0.000313	0.0015	CcSEcCtD
Rabeprazole—Cough—Bleomycin—melanoma	0.000313	0.0015	CcSEcCtD
Rabeprazole—Chills—Temozolomide—melanoma	0.000312	0.0015	CcSEcCtD
Rabeprazole—Dehydration—Docetaxel—melanoma	0.000311	0.00149	CcSEcCtD
Rabeprazole—Ill-defined disorder—Dactinomycin—melanoma	0.000311	0.00149	CcSEcCtD
Rabeprazole—Anaemia—Dactinomycin—melanoma	0.00031	0.00148	CcSEcCtD
Rabeprazole—Liver function test abnormal—Docetaxel—melanoma	0.000309	0.00148	CcSEcCtD
Rabeprazole—Vomiting—Vemurafenib—melanoma	0.000308	0.00147	CcSEcCtD
Rabeprazole—Alopecia—Temozolomide—melanoma	0.000307	0.00147	CcSEcCtD
Rabeprazole—Dry skin—Docetaxel—melanoma	0.000307	0.00147	CcSEcCtD
Rabeprazole—Chest pain—Bleomycin—melanoma	0.000306	0.00146	CcSEcCtD
Rabeprazole—Myalgia—Bleomycin—melanoma	0.000306	0.00146	CcSEcCtD
Rabeprazole—Abdominal pain upper—Docetaxel—melanoma	0.000305	0.00146	CcSEcCtD
Rabeprazole—Rash—Vemurafenib—melanoma	0.000305	0.00146	CcSEcCtD
Rabeprazole—Dermatitis—Vemurafenib—melanoma	0.000305	0.00146	CcSEcCtD
Rabeprazole—Back pain—Carmustine—melanoma	0.000303	0.00145	CcSEcCtD
Rabeprazole—Headache—Vemurafenib—melanoma	0.000303	0.00145	CcSEcCtD
Rabeprazole—Malnutrition—Temozolomide—melanoma	0.000303	0.00145	CcSEcCtD
Rabeprazole—Erythema—Temozolomide—melanoma	0.000303	0.00145	CcSEcCtD
Rabeprazole—Discomfort—Bleomycin—melanoma	0.000302	0.00145	CcSEcCtD
Rabeprazole—Malaise—Dactinomycin—melanoma	0.000302	0.00145	CcSEcCtD
Rabeprazole—Toxic epidermal necrolysis—Docetaxel—melanoma	0.000301	0.00144	CcSEcCtD
Rabeprazole—Leukopenia—Dactinomycin—melanoma	0.0003	0.00144	CcSEcCtD
Rabeprazole—Dysgeusia—Temozolomide—melanoma	0.000297	0.00142	CcSEcCtD
Rabeprazole—Confusional state—Bleomycin—melanoma	0.000295	0.00142	CcSEcCtD
Rabeprazole—Vision blurred—Carmustine—melanoma	0.000295	0.00142	CcSEcCtD
Rabeprazole—Alanine aminotransferase increased—Docetaxel—melanoma	0.000295	0.00141	CcSEcCtD
Rabeprazole—Tremor—Carmustine—melanoma	0.000294	0.00141	CcSEcCtD
Rabeprazole—Anaphylactic shock—Bleomycin—melanoma	0.000293	0.0014	CcSEcCtD
Rabeprazole—Oedema—Bleomycin—melanoma	0.000293	0.0014	CcSEcCtD
Rabeprazole—Back pain—Temozolomide—melanoma	0.000293	0.0014	CcSEcCtD
Rabeprazole—Anaemia—Carmustine—melanoma	0.00029	0.00139	CcSEcCtD
Rabeprazole—Dysphagia—Docetaxel—melanoma	0.000289	0.00138	CcSEcCtD
Rabeprazole—Agitation—Carmustine—melanoma	0.000288	0.00138	CcSEcCtD
Rabeprazole—Nausea—Vemurafenib—melanoma	0.000287	0.00138	CcSEcCtD
Rabeprazole—Thrombocytopenia—Bleomycin—melanoma	0.000287	0.00137	CcSEcCtD
Rabeprazole—Vision blurred—Temozolomide—melanoma	0.000285	0.00137	CcSEcCtD
Rabeprazole—Myalgia—Dactinomycin—melanoma	0.000285	0.00137	CcSEcCtD
Rabeprazole—Tremor—Temozolomide—melanoma	0.000284	0.00136	CcSEcCtD
Rabeprazole—Discomfort—Dactinomycin—melanoma	0.000282	0.00135	CcSEcCtD
Rabeprazole—Angina pectoris—Docetaxel—melanoma	0.000282	0.00135	CcSEcCtD
Rabeprazole—Ill-defined disorder—Temozolomide—melanoma	0.000281	0.00135	CcSEcCtD
Rabeprazole—Leukopenia—Carmustine—melanoma	0.000281	0.00134	CcSEcCtD
Rabeprazole—Anaemia—Temozolomide—melanoma	0.00028	0.00134	CcSEcCtD
Rabeprazole—Anorexia—Bleomycin—melanoma	0.000279	0.00134	CcSEcCtD
Rabeprazole—Agitation—Temozolomide—melanoma	0.000278	0.00133	CcSEcCtD
Rabeprazole—Angioedema—Temozolomide—melanoma	0.000277	0.00133	CcSEcCtD
Rabeprazole—Pancytopenia—Docetaxel—melanoma	0.000275	0.00132	CcSEcCtD
Rabeprazole—Hypotension—Bleomycin—melanoma	0.000274	0.00131	CcSEcCtD
Rabeprazole—Oedema—Dactinomycin—melanoma	0.000273	0.00131	CcSEcCtD
Rabeprazole—Malaise—Temozolomide—melanoma	0.000273	0.00131	CcSEcCtD
Rabeprazole—Vertigo—Temozolomide—melanoma	0.000272	0.0013	CcSEcCtD
Rabeprazole—Convulsion—Carmustine—melanoma	0.000272	0.0013	CcSEcCtD
Rabeprazole—Leukopenia—Temozolomide—melanoma	0.000271	0.0013	CcSEcCtD
Rabeprazole—Hypertension—Carmustine—melanoma	0.000271	0.0013	CcSEcCtD
Rabeprazole—Neutropenia—Docetaxel—melanoma	0.00027	0.0013	CcSEcCtD
Rabeprazole—Palpitations—Temozolomide—melanoma	0.000268	0.00128	CcSEcCtD
Rabeprazole—Thrombocytopenia—Dactinomycin—melanoma	0.000268	0.00128	CcSEcCtD
Rabeprazole—Musculoskeletal discomfort—Bleomycin—melanoma	0.000267	0.00128	CcSEcCtD
Rabeprazole—Chest pain—Carmustine—melanoma	0.000267	0.00128	CcSEcCtD
Rabeprazole—Myalgia—Carmustine—melanoma	0.000267	0.00128	CcSEcCtD
Rabeprazole—Anxiety—Carmustine—melanoma	0.000266	0.00127	CcSEcCtD
Rabeprazole—Cough—Temozolomide—melanoma	0.000264	0.00127	CcSEcCtD
Rabeprazole—Paraesthesia—Bleomycin—melanoma	0.000263	0.00126	CcSEcCtD
Rabeprazole—Weight increased—Docetaxel—melanoma	0.000263	0.00126	CcSEcCtD
Rabeprazole—Convulsion—Temozolomide—melanoma	0.000262	0.00126	CcSEcCtD
Rabeprazole—Weight decreased—Docetaxel—melanoma	0.000262	0.00125	CcSEcCtD
Rabeprazole—Hypertension—Temozolomide—melanoma	0.000262	0.00125	CcSEcCtD
Rabeprazole—Dyspnoea—Bleomycin—melanoma	0.000261	0.00125	CcSEcCtD
Rabeprazole—Anorexia—Dactinomycin—melanoma	0.000261	0.00125	CcSEcCtD
Rabeprazole—Pneumonia—Docetaxel—melanoma	0.000259	0.00124	CcSEcCtD
Rabeprazole—Confusional state—Carmustine—melanoma	0.000258	0.00124	CcSEcCtD
Rabeprazole—Myalgia—Temozolomide—melanoma	0.000258	0.00124	CcSEcCtD
Rabeprazole—Arthralgia—Temozolomide—melanoma	0.000258	0.00124	CcSEcCtD
Rabeprazole—Anxiety—Temozolomide—melanoma	0.000257	0.00123	CcSEcCtD
Rabeprazole—Oedema—Carmustine—melanoma	0.000256	0.00123	CcSEcCtD
Rabeprazole—Stevens-Johnson syndrome—Docetaxel—melanoma	0.000256	0.00122	CcSEcCtD
Rabeprazole—Discomfort—Temozolomide—melanoma	0.000255	0.00122	CcSEcCtD
Rabeprazole—Decreased appetite—Bleomycin—melanoma	0.000255	0.00122	CcSEcCtD
Rabeprazole—Acute coronary syndrome—Docetaxel—melanoma	0.000254	0.00122	CcSEcCtD
Rabeprazole—Neuropathy peripheral—Docetaxel—melanoma	0.000253	0.00121	CcSEcCtD
Rabeprazole—Myocardial infarction—Docetaxel—melanoma	0.000253	0.00121	CcSEcCtD
Rabeprazole—Dry mouth—Temozolomide—melanoma	0.000252	0.00121	CcSEcCtD
Rabeprazole—Stomatitis—Docetaxel—melanoma	0.000251	0.0012	CcSEcCtD
Rabeprazole—Jaundice—Docetaxel—melanoma	0.000251	0.0012	CcSEcCtD
Rabeprazole—Pain—Bleomycin—melanoma	0.000251	0.0012	CcSEcCtD
Rabeprazole—Conjunctivitis—Docetaxel—melanoma	0.000251	0.0012	CcSEcCtD
Rabeprazole—Thrombocytopenia—Carmustine—melanoma	0.00025	0.0012	CcSEcCtD
Rabeprazole—Tachycardia—Carmustine—melanoma	0.00025	0.0012	CcSEcCtD
Rabeprazole—Confusional state—Temozolomide—melanoma	0.000249	0.00119	CcSEcCtD
Rabeprazole—Musculoskeletal discomfort—Dactinomycin—melanoma	0.000249	0.00119	CcSEcCtD
Rabeprazole—Anaphylactic shock—Temozolomide—melanoma	0.000247	0.00118	CcSEcCtD
Rabeprazole—Oedema—Temozolomide—melanoma	0.000247	0.00118	CcSEcCtD
Rabeprazole—Anorexia—Carmustine—melanoma	0.000244	0.00117	CcSEcCtD
Rabeprazole—Epistaxis—Docetaxel—melanoma	0.000243	0.00116	CcSEcCtD
Rabeprazole—Thrombocytopenia—Temozolomide—melanoma	0.000242	0.00116	CcSEcCtD
Rabeprazole—Feeling abnormal—Bleomycin—melanoma	0.000241	0.00116	CcSEcCtD
Rabeprazole—Agranulocytosis—Docetaxel—melanoma	0.000241	0.00115	CcSEcCtD
Rabeprazole—Hypotension—Carmustine—melanoma	0.000239	0.00115	CcSEcCtD
Rabeprazole—Hyperhidrosis—Temozolomide—melanoma	0.000239	0.00114	CcSEcCtD
Rabeprazole—Decreased appetite—Dactinomycin—melanoma	0.000238	0.00114	CcSEcCtD
Rabeprazole—Anorexia—Temozolomide—melanoma	0.000236	0.00113	CcSEcCtD
Rabeprazole—Pain—Dactinomycin—melanoma	0.000234	0.00112	CcSEcCtD
Rabeprazole—Musculoskeletal discomfort—Carmustine—melanoma	0.000233	0.00112	CcSEcCtD
Rabeprazole—Urticaria—Bleomycin—melanoma	0.000233	0.00112	CcSEcCtD
Rabeprazole—Rhinitis—Docetaxel—melanoma	0.000232	0.00111	CcSEcCtD
Rabeprazole—Body temperature increased—Bleomycin—melanoma	0.000232	0.00111	CcSEcCtD
Rabeprazole—Hepatitis—Docetaxel—melanoma	0.000231	0.00111	CcSEcCtD
Rabeprazole—Insomnia—Carmustine—melanoma	0.000231	0.00111	CcSEcCtD
Rabeprazole—Paraesthesia—Carmustine—melanoma	0.00023	0.0011	CcSEcCtD
Rabeprazole—Pharyngitis—Docetaxel—melanoma	0.00023	0.0011	CcSEcCtD
Rabeprazole—Urinary tract disorder—Docetaxel—melanoma	0.000229	0.00109	CcSEcCtD
Rabeprazole—Dyspnoea—Carmustine—melanoma	0.000228	0.00109	CcSEcCtD
Rabeprazole—Oedema peripheral—Docetaxel—melanoma	0.000228	0.00109	CcSEcCtD
Rabeprazole—Somnolence—Carmustine—melanoma	0.000227	0.00109	CcSEcCtD
Rabeprazole—Urethral disorder—Docetaxel—melanoma	0.000227	0.00109	CcSEcCtD
Rabeprazole—Feeling abnormal—Dactinomycin—melanoma	0.000225	0.00108	CcSEcCtD
Rabeprazole—Musculoskeletal discomfort—Temozolomide—melanoma	0.000225	0.00108	CcSEcCtD
Rabeprazole—Insomnia—Temozolomide—melanoma	0.000224	0.00107	CcSEcCtD
Rabeprazole—Gastrointestinal pain—Dactinomycin—melanoma	0.000223	0.00107	CcSEcCtD
Rabeprazole—Visual impairment—Docetaxel—melanoma	0.000223	0.00107	CcSEcCtD
Rabeprazole—Decreased appetite—Carmustine—melanoma	0.000222	0.00107	CcSEcCtD
Rabeprazole—Paraesthesia—Temozolomide—melanoma	0.000222	0.00106	CcSEcCtD
Rabeprazole—Dyspnoea—Temozolomide—melanoma	0.00022	0.00106	CcSEcCtD
Rabeprazole—Somnolence—Temozolomide—melanoma	0.00022	0.00105	CcSEcCtD
Rabeprazole—Erythema multiforme—Docetaxel—melanoma	0.000219	0.00105	CcSEcCtD
Rabeprazole—Pain—Carmustine—melanoma	0.000219	0.00105	CcSEcCtD
Rabeprazole—Constipation—Carmustine—melanoma	0.000219	0.00105	CcSEcCtD
Rabeprazole—Dyspepsia—Temozolomide—melanoma	0.000218	0.00104	CcSEcCtD
Rabeprazole—Eye disorder—Docetaxel—melanoma	0.000216	0.00104	CcSEcCtD
Rabeprazole—Body temperature increased—Dactinomycin—melanoma	0.000216	0.00104	CcSEcCtD
Rabeprazole—Abdominal pain—Dactinomycin—melanoma	0.000216	0.00104	CcSEcCtD
Rabeprazole—Hypersensitivity—Bleomycin—melanoma	0.000216	0.00103	CcSEcCtD
Rabeprazole—Decreased appetite—Temozolomide—melanoma	0.000215	0.00103	CcSEcCtD
Rabeprazole—Pain—Temozolomide—melanoma	0.000211	0.00101	CcSEcCtD
Rabeprazole—Constipation—Temozolomide—melanoma	0.000211	0.00101	CcSEcCtD
Rabeprazole—Feeling abnormal—Carmustine—melanoma	0.000211	0.00101	CcSEcCtD
Rabeprazole—Asthenia—Bleomycin—melanoma	0.00021	0.00101	CcSEcCtD
Rabeprazole—Angiopathy—Docetaxel—melanoma	0.00021	0.00101	CcSEcCtD
Rabeprazole—Gastrointestinal pain—Carmustine—melanoma	0.000209	0.001	CcSEcCtD
Rabeprazole—Chills—Docetaxel—melanoma	0.000208	0.000995	CcSEcCtD
Rabeprazole—Pruritus—Bleomycin—melanoma	0.000207	0.000993	CcSEcCtD
Rabeprazole—Arrhythmia—Docetaxel—melanoma	0.000207	0.00099	CcSEcCtD
Rabeprazole—Alopecia—Docetaxel—melanoma	0.000204	0.00098	CcSEcCtD
Rabeprazole—Feeling abnormal—Temozolomide—melanoma	0.000204	0.000976	CcSEcCtD
Rabeprazole—Abdominal pain—Carmustine—melanoma	0.000202	0.000969	CcSEcCtD
Rabeprazole—Body temperature increased—Carmustine—melanoma	0.000202	0.000969	CcSEcCtD
Rabeprazole—Gastrointestinal pain—Temozolomide—melanoma	0.000202	0.000968	CcSEcCtD
Rabeprazole—Malnutrition—Docetaxel—melanoma	0.000201	0.000965	CcSEcCtD
Rabeprazole—Erythema—Docetaxel—melanoma	0.000201	0.000965	CcSEcCtD
Rabeprazole—Hypersensitivity—Dactinomycin—melanoma	0.000201	0.000965	CcSEcCtD
Rabeprazole—Dysgeusia—Docetaxel—melanoma	0.000197	0.000945	CcSEcCtD
Rabeprazole—Urticaria—Temozolomide—melanoma	0.000196	0.000941	CcSEcCtD
Rabeprazole—Asthenia—Dactinomycin—melanoma	0.000196	0.000939	CcSEcCtD
Rabeprazole—Abdominal pain—Temozolomide—melanoma	0.000195	0.000936	CcSEcCtD
Rabeprazole—Body temperature increased—Temozolomide—melanoma	0.000195	0.000936	CcSEcCtD
Rabeprazole—Back pain—Docetaxel—melanoma	0.000195	0.000933	CcSEcCtD
Rabeprazole—Muscle spasms—Docetaxel—melanoma	0.000194	0.000928	CcSEcCtD
Rabeprazole—Hypersensitivity—Carmustine—melanoma	0.000188	0.000903	CcSEcCtD
Rabeprazole—Diarrhoea—Dactinomycin—melanoma	0.000187	0.000896	CcSEcCtD
Rabeprazole—Vomiting—Bleomycin—melanoma	0.000186	0.000893	CcSEcCtD
Rabeprazole—Anaemia—Docetaxel—melanoma	0.000186	0.000892	CcSEcCtD
Rabeprazole—Rash—Bleomycin—melanoma	0.000185	0.000885	CcSEcCtD
Rabeprazole—Dermatitis—Bleomycin—melanoma	0.000185	0.000884	CcSEcCtD
Rabeprazole—Asthenia—Carmustine—melanoma	0.000184	0.000879	CcSEcCtD
Rabeprazole—Hypersensitivity—Temozolomide—melanoma	0.000182	0.000873	CcSEcCtD
Rabeprazole—Syncope—Docetaxel—melanoma	0.000181	0.000865	CcSEcCtD
Rabeprazole—Leukopenia—Docetaxel—melanoma	0.00018	0.000864	CcSEcCtD
Rabeprazole—Palpitations—Docetaxel—melanoma	0.000178	0.000853	CcSEcCtD
Rabeprazole—Asthenia—Temozolomide—melanoma	0.000177	0.00085	CcSEcCtD
Rabeprazole—Loss of consciousness—Docetaxel—melanoma	0.000177	0.000848	CcSEcCtD
Rabeprazole—Cough—Docetaxel—melanoma	0.000176	0.000842	CcSEcCtD
Rabeprazole—Diarrhoea—Carmustine—melanoma	0.000175	0.000838	CcSEcCtD
Rabeprazole—Pruritus—Temozolomide—melanoma	0.000175	0.000838	CcSEcCtD
Rabeprazole—Convulsion—Docetaxel—melanoma	0.000175	0.000836	CcSEcCtD
Rabeprazole—Nausea—Bleomycin—melanoma	0.000174	0.000834	CcSEcCtD
Rabeprazole—Hypertension—Docetaxel—melanoma	0.000174	0.000833	CcSEcCtD
Rabeprazole—Vomiting—Dactinomycin—melanoma	0.000174	0.000832	CcSEcCtD
Rabeprazole—Rash—Dactinomycin—melanoma	0.000172	0.000826	CcSEcCtD
Rabeprazole—Chest pain—Docetaxel—melanoma	0.000171	0.000822	CcSEcCtD
Rabeprazole—Arthralgia—Docetaxel—melanoma	0.000171	0.000822	CcSEcCtD
Rabeprazole—Myalgia—Docetaxel—melanoma	0.000171	0.000822	CcSEcCtD
Rabeprazole—Dizziness—Carmustine—melanoma	0.000169	0.00081	CcSEcCtD
Rabeprazole—Diarrhoea—Temozolomide—melanoma	0.000169	0.00081	CcSEcCtD
Rabeprazole—Dry mouth—Docetaxel—melanoma	0.000168	0.000803	CcSEcCtD
Rabeprazole—Confusional state—Docetaxel—melanoma	0.000166	0.000794	CcSEcCtD
Rabeprazole—Oedema—Docetaxel—melanoma	0.000164	0.000788	CcSEcCtD
Rabeprazole—Anaphylactic shock—Docetaxel—melanoma	0.000164	0.000788	CcSEcCtD
Rabeprazole—Dizziness—Temozolomide—melanoma	0.000163	0.000783	CcSEcCtD
Rabeprazole—Vomiting—Carmustine—melanoma	0.000163	0.000779	CcSEcCtD
Rabeprazole—Nausea—Dactinomycin—melanoma	0.000162	0.000778	CcSEcCtD
Rabeprazole—Shock—Docetaxel—melanoma	0.000162	0.000775	CcSEcCtD
Rabeprazole—Rash—Carmustine—melanoma	0.000161	0.000773	CcSEcCtD
Rabeprazole—Dermatitis—Carmustine—melanoma	0.000161	0.000772	CcSEcCtD
Rabeprazole—Thrombocytopenia—Docetaxel—melanoma	0.000161	0.000771	CcSEcCtD
Rabeprazole—Tachycardia—Docetaxel—melanoma	0.00016	0.000769	CcSEcCtD
Rabeprazole—Headache—Carmustine—melanoma	0.00016	0.000768	CcSEcCtD
Rabeprazole—Vomiting—Temozolomide—melanoma	0.000157	0.000753	CcSEcCtD
Rabeprazole—Anorexia—Docetaxel—melanoma	0.000157	0.000751	CcSEcCtD
Rabeprazole—Rash—Temozolomide—melanoma	0.000156	0.000747	CcSEcCtD
Rabeprazole—Dermatitis—Temozolomide—melanoma	0.000156	0.000746	CcSEcCtD
Rabeprazole—Headache—Temozolomide—melanoma	0.000155	0.000742	CcSEcCtD
Rabeprazole—Hypotension—Docetaxel—melanoma	0.000154	0.000736	CcSEcCtD
Rabeprazole—Nausea—Carmustine—melanoma	0.000152	0.000728	CcSEcCtD
Rabeprazole—Musculoskeletal discomfort—Docetaxel—melanoma	0.00015	0.000718	CcSEcCtD
Rabeprazole—Insomnia—Docetaxel—melanoma	0.000149	0.000712	CcSEcCtD
Rabeprazole—Paraesthesia—Docetaxel—melanoma	0.000148	0.000707	CcSEcCtD
Rabeprazole—Nausea—Temozolomide—melanoma	0.000147	0.000703	CcSEcCtD
Rabeprazole—Dyspnoea—Docetaxel—melanoma	0.000147	0.000702	CcSEcCtD
Rabeprazole—Somnolence—Docetaxel—melanoma	0.000146	0.0007	CcSEcCtD
Rabeprazole—Dyspepsia—Docetaxel—melanoma	0.000145	0.000693	CcSEcCtD
Rabeprazole—Decreased appetite—Docetaxel—melanoma	0.000143	0.000685	CcSEcCtD
Rabeprazole—Constipation—Docetaxel—melanoma	0.000141	0.000673	CcSEcCtD
Rabeprazole—Pain—Docetaxel—melanoma	0.000141	0.000673	CcSEcCtD
Rabeprazole—Feeling abnormal—Docetaxel—melanoma	0.000135	0.000649	CcSEcCtD
Rabeprazole—Gastrointestinal pain—Docetaxel—melanoma	0.000134	0.000644	CcSEcCtD
Rabeprazole—Body temperature increased—Docetaxel—melanoma	0.00013	0.000623	CcSEcCtD
Rabeprazole—Abdominal pain—Docetaxel—melanoma	0.00013	0.000623	CcSEcCtD
Rabeprazole—Hypersensitivity—Docetaxel—melanoma	0.000121	0.00058	CcSEcCtD
Rabeprazole—Asthenia—Docetaxel—melanoma	0.000118	0.000565	CcSEcCtD
Rabeprazole—Pruritus—Docetaxel—melanoma	0.000116	0.000557	CcSEcCtD
Rabeprazole—Diarrhoea—Docetaxel—melanoma	0.000112	0.000539	CcSEcCtD
Rabeprazole—Dizziness—Docetaxel—melanoma	0.000109	0.000521	CcSEcCtD
Rabeprazole—Vomiting—Docetaxel—melanoma	0.000105	0.000501	CcSEcCtD
Rabeprazole—Rash—Docetaxel—melanoma	0.000104	0.000497	CcSEcCtD
Rabeprazole—Dermatitis—Docetaxel—melanoma	0.000104	0.000496	CcSEcCtD
Rabeprazole—Headache—Docetaxel—melanoma	0.000103	0.000493	CcSEcCtD
Rabeprazole—Nausea—Docetaxel—melanoma	9.76e-05	0.000468	CcSEcCtD
Rabeprazole—CYP2C19—Metabolism—PIP4K2A—melanoma	1.83e-05	0.000382	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—SLC6A11—melanoma	1.83e-05	0.000382	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—ACER3—melanoma	1.81e-05	0.000379	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—CSPG4—melanoma	1.8e-05	0.000376	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—BSG—melanoma	1.8e-05	0.000376	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—SDHD—melanoma	1.8e-05	0.000376	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—PLCB4—melanoma	1.79e-05	0.000373	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—MTAP—melanoma	1.78e-05	0.000371	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—PLCB4—melanoma	1.77e-05	0.00037	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—GPAM—melanoma	1.74e-05	0.000364	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism of lipids and lipoproteins—FASN—melanoma	1.74e-05	0.000363	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism of lipids and lipoproteins—CYP1B1—melanoma	1.74e-05	0.000363	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—SLC6A11—melanoma	1.68e-05	0.000351	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—PIP4K2A—melanoma	1.68e-05	0.000351	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—SLC6A11—melanoma	1.66e-05	0.000348	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—PIP4K2A—melanoma	1.66e-05	0.000348	CbGpPWpGaD
Rabeprazole—ABCG2—Metabolism—CYP17A1—melanoma	1.66e-05	0.000347	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—UGT2B10—melanoma	1.66e-05	0.000346	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—MTAP—melanoma	1.63e-05	0.000341	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—MTAP—melanoma	1.62e-05	0.000338	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism of lipids and lipoproteins—CYP17A1—melanoma	1.61e-05	0.000336	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—PHGDH—melanoma	1.58e-05	0.000331	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—LUM—melanoma	1.58e-05	0.000331	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism of lipids and lipoproteins—CYP1B1—melanoma	1.58e-05	0.000331	CbGpPWpGaD
Rabeprazole—ABCG2—Metabolism—GNA11—melanoma	1.57e-05	0.000327	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—HPSE—melanoma	1.55e-05	0.000324	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—HS3ST5—melanoma	1.54e-05	0.000322	CbGpPWpGaD
Rabeprazole—ABCG2—Transmembrane transport of small molecules—ALB—melanoma	1.53e-05	0.000321	CbGpPWpGaD
Rabeprazole—ABCG2—Metabolism—FASN—melanoma	1.53e-05	0.00032	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—CUBN—melanoma	1.52e-05	0.000318	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—PLCB4—melanoma	1.51e-05	0.000316	CbGpPWpGaD
Rabeprazole—ABCG2—Metabolism—SLC5A5—melanoma	1.51e-05	0.000315	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism of lipids and lipoproteins—FASN—melanoma	1.48e-05	0.00031	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—PLA2G6—melanoma	1.48e-05	0.000309	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—SDHD—melanoma	1.47e-05	0.000308	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—BSG—melanoma	1.47e-05	0.000308	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—CSPG4—melanoma	1.47e-05	0.000308	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—LUM—melanoma	1.46e-05	0.000304	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—PHGDH—melanoma	1.46e-05	0.000304	CbGpPWpGaD
Rabeprazole—ABCG2—Metabolism—GNAQ—melanoma	1.46e-05	0.000304	CbGpPWpGaD
Rabeprazole—ABCG2—Metabolism—CD44—melanoma	1.46e-05	0.000304	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—PHGDH—melanoma	1.44e-05	0.000302	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—LUM—melanoma	1.44e-05	0.000302	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—HPSE—melanoma	1.43e-05	0.000298	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—GPAM—melanoma	1.43e-05	0.000298	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—SLC6A11—melanoma	1.42e-05	0.000297	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—PIP4K2A—melanoma	1.42e-05	0.000297	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—HPSE—melanoma	1.42e-05	0.000296	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—CUBN—melanoma	1.4e-05	0.000293	CbGpPWpGaD
Rabeprazole—ABCG2—Metabolism—CYP1B1—melanoma	1.4e-05	0.000292	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—CUBN—melanoma	1.39e-05	0.00029	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—MTAP—melanoma	1.38e-05	0.000289	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—SDHD—melanoma	1.35e-05	0.000283	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—BSG—melanoma	1.35e-05	0.000283	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—CSPG4—melanoma	1.35e-05	0.000283	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism of lipids and lipoproteins—CYP1B1—melanoma	1.35e-05	0.000283	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—SDHD—melanoma	1.34e-05	0.00028	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—BSG—melanoma	1.34e-05	0.00028	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—CSPG4—melanoma	1.34e-05	0.00028	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—VCAN—melanoma	1.33e-05	0.000278	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—GPAM—melanoma	1.31e-05	0.000274	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—GPAM—melanoma	1.3e-05	0.000272	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	1.26e-05	0.000263	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—PHGDH—melanoma	1.23e-05	0.000258	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—LUM—melanoma	1.23e-05	0.000258	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism of lipids and lipoproteins—PPARG—melanoma	1.22e-05	0.000254	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—PLA2G6—melanoma	1.21e-05	0.000253	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—HPSE—melanoma	1.21e-05	0.000253	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—CUBN—melanoma	1.19e-05	0.000248	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—PLCB4—melanoma	1.17e-05	0.000244	CbGpPWpGaD
Rabeprazole—ABCG2—Metabolism—ABCB1—melanoma	1.15e-05	0.00024	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—CSPG4—melanoma	1.15e-05	0.00024	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—SDHD—melanoma	1.15e-05	0.00024	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—BSG—melanoma	1.15e-05	0.00024	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—CYP17A1—melanoma	1.12e-05	0.000235	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—PLA2G6—melanoma	1.11e-05	0.000233	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—GPAM—melanoma	1.11e-05	0.000232	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	1.11e-05	0.000231	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—PLA2G6—melanoma	1.1e-05	0.000231	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—SLC6A11—melanoma	1.1e-05	0.000229	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—PIP4K2A—melanoma	1.1e-05	0.000229	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism of lipids and lipoproteins—ALB—melanoma	1.09e-05	0.000228	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—VCAN—melanoma	1.09e-05	0.000227	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—MTAP—melanoma	1.07e-05	0.000223	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—GNA11—melanoma	1.06e-05	0.000222	CbGpPWpGaD
Rabeprazole—ABCG2—Metabolism—PRKCA—melanoma	1.06e-05	0.000221	CbGpPWpGaD
Rabeprazole—ABCG2—Metabolism—ERCC2—melanoma	1.05e-05	0.000219	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—FASN—melanoma	1.04e-05	0.000217	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	1.03e-05	0.000215	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—SLC5A5—melanoma	1.02e-05	0.000213	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—VCAN—melanoma	1e-05	0.000209	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—melanoma	9.94e-06	0.000208	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—VCAN—melanoma	9.93e-06	0.000207	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—CD44—melanoma	9.85e-06	0.000206	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—GNAQ—melanoma	9.85e-06	0.000206	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	9.65e-06	0.000202	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—melanoma	9.56e-06	0.0002	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—PHGDH—melanoma	9.52e-06	0.000199	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—LUM—melanoma	9.52e-06	0.000199	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—CYP1B1—melanoma	9.45e-06	0.000197	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—PLA2G6—melanoma	9.44e-06	0.000197	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	9.39e-06	0.000196	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—HPSE—melanoma	9.33e-06	0.000195	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—CYP17A1—melanoma	9.18e-06	0.000192	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—CUBN—melanoma	9.16e-06	0.000191	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—melanoma	9.07e-06	0.00019	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	9.06e-06	0.000189	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism of lipids and lipoproteins—ALB—melanoma	8.94e-06	0.000187	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—SDHD—melanoma	8.85e-06	0.000185	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—CSPG4—melanoma	8.85e-06	0.000185	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—BSG—melanoma	8.85e-06	0.000185	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—GNA11—melanoma	8.67e-06	0.000181	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—GPAM—melanoma	8.57e-06	0.000179	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—FASN—melanoma	8.49e-06	0.000177	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—VCAN—melanoma	8.48e-06	0.000177	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—CYP17A1—melanoma	8.45e-06	0.000177	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—CYP17A1—melanoma	8.37e-06	0.000175	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—SLC5A5—melanoma	8.35e-06	0.000174	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism of lipids and lipoproteins—PTEN—melanoma	8.34e-06	0.000174	CbGpPWpGaD
Rabeprazole—ABCG2—Metabolism—PIK3CG—melanoma	8.28e-06	0.000173	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	8.26e-06	0.000173	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism of lipids and lipoproteins—ALB—melanoma	8.15e-06	0.00017	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—GNAQ—melanoma	8.06e-06	0.000169	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—CD44—melanoma	8.06e-06	0.000169	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	8.03e-06	0.000168	CbGpPWpGaD
Rabeprazole—ABCG2—Metabolism—PPARG—melanoma	8e-06	0.000167	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—GNA11—melanoma	7.98e-06	0.000167	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—GNA11—melanoma	7.91e-06	0.000165	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	7.9e-06	0.000165	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—melanoma	7.82e-06	0.000163	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—FASN—melanoma	7.81e-06	0.000163	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—ABCB1—melanoma	7.78e-06	0.000163	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—melanoma	7.75e-06	0.000162	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—FASN—melanoma	7.74e-06	0.000162	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—CYP1B1—melanoma	7.73e-06	0.000162	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—SLC5A5—melanoma	7.68e-06	0.00016	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—SLC5A5—melanoma	7.61e-06	0.000159	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—GNAQ—melanoma	7.42e-06	0.000155	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—CD44—melanoma	7.42e-06	0.000155	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—GNAQ—melanoma	7.35e-06	0.000154	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—CD44—melanoma	7.35e-06	0.000154	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—PLA2G6—melanoma	7.29e-06	0.000152	CbGpPWpGaD
Rabeprazole—ABCG2—Metabolism—PIK3CD—melanoma	7.28e-06	0.000152	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	7.2e-06	0.00015	CbGpPWpGaD
Rabeprazole—ABCG2—Metabolism—ALB—melanoma	7.19e-06	0.00015	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—PRKCA—melanoma	7.16e-06	0.00015	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—CYP17A1—melanoma	7.16e-06	0.00015	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—melanoma	7.13e-06	0.000149	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—CYP1B1—melanoma	7.11e-06	0.000149	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—ERCC2—melanoma	7.1e-06	0.000148	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	7.06e-06	0.000148	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—CYP1B1—melanoma	7.05e-06	0.000147	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism of lipids and lipoproteins—ALB—melanoma	6.97e-06	0.000146	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—melanoma	6.82e-06	0.000143	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—GNA11—melanoma	6.76e-06	0.000141	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—FASN—melanoma	6.61e-06	0.000138	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—VCAN—melanoma	6.55e-06	0.000137	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—SLC5A5—melanoma	6.5e-06	0.000136	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—ABCB1—melanoma	6.37e-06	0.000133	CbGpPWpGaD
Rabeprazole—ABCG2—Metabolism—PIK3CB—melanoma	6.35e-06	0.000133	CbGpPWpGaD
Rabeprazole—ABCG2—Metabolism—PTGS2—melanoma	6.29e-06	0.000131	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—CD44—melanoma	6.28e-06	0.000131	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—GNAQ—melanoma	6.28e-06	0.000131	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—melanoma	6.22e-06	0.00013	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	6.15e-06	0.000129	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—melanoma	6.1e-06	0.000127	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—CYP1B1—melanoma	6.02e-06	0.000126	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	5.88e-06	0.000123	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—PRKCA—melanoma	5.86e-06	0.000122	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—ABCB1—melanoma	5.85e-06	0.000122	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—ERCC2—melanoma	5.81e-06	0.000121	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—ABCB1—melanoma	5.8e-06	0.000121	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—PIK3CG—melanoma	5.61e-06	0.000117	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—CYP17A1—melanoma	5.52e-06	0.000115	CbGpPWpGaD
Rabeprazole—ABCG2—Metabolism—PTEN—melanoma	5.49e-06	0.000115	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—PPARG—melanoma	5.41e-06	0.000113	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—PRKCA—melanoma	5.39e-06	0.000113	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—ERCC2—melanoma	5.34e-06	0.000112	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—PRKCA—melanoma	5.34e-06	0.000112	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—melanoma	5.32e-06	0.000111	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—ERCC2—melanoma	5.3e-06	0.000111	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—GNA11—melanoma	5.22e-06	0.000109	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—FASN—melanoma	5.1e-06	0.000107	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—SLC5A5—melanoma	5.02e-06	0.000105	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—ABCB1—melanoma	4.96e-06	0.000104	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—PIK3CD—melanoma	4.93e-06	0.000103	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—ALB—melanoma	4.87e-06	0.000102	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—GNAQ—melanoma	4.85e-06	0.000101	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—CD44—melanoma	4.85e-06	0.000101	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	4.81e-06	0.000101	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—CYP1B1—melanoma	4.65e-06	9.72e-05	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—PIK3CG—melanoma	4.59e-06	9.59e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—PRKCA—melanoma	4.56e-06	9.54e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—ERCC2—melanoma	4.53e-06	9.46e-05	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—PPARG—melanoma	4.43e-06	9.26e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	4.39e-06	9.17e-05	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—PIK3CB—melanoma	4.3e-06	8.98e-05	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—PTGS2—melanoma	4.26e-06	8.9e-05	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—PIK3CG—melanoma	4.22e-06	8.82e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—PIK3CG—melanoma	4.18e-06	8.74e-05	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—PPARG—melanoma	4.07e-06	8.51e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—PPARG—melanoma	4.04e-06	8.44e-05	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—PIK3CD—melanoma	4.03e-06	8.43e-05	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—ALB—melanoma	3.98e-06	8.32e-05	CbGpPWpGaD
Rabeprazole—ABCG2—Metabolism—PIK3CA—melanoma	3.87e-06	8.09e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—ABCB1—melanoma	3.83e-06	8e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	3.75e-06	7.84e-05	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—PTEN—melanoma	3.71e-06	7.76e-05	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—PIK3CD—melanoma	3.71e-06	7.75e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—PIK3CD—melanoma	3.68e-06	7.69e-05	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—ALB—melanoma	3.66e-06	7.65e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—ALB—melanoma	3.63e-06	7.59e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—PIK3CG—melanoma	3.58e-06	7.47e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—PRKCA—melanoma	3.52e-06	7.36e-05	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—PIK3CB—melanoma	3.52e-06	7.35e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—ERCC2—melanoma	3.49e-06	7.3e-05	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—PTGS2—melanoma	3.48e-06	7.28e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—PPARG—melanoma	3.45e-06	7.21e-05	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—PIK3CB—melanoma	3.23e-06	6.76e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—PIK3CB—melanoma	3.21e-06	6.7e-05	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—PTGS2—melanoma	3.2e-06	6.7e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—PTGS2—melanoma	3.18e-06	6.64e-05	CbGpPWpGaD
Rabeprazole—ABCG2—Metabolism—AKT1—melanoma	3.16e-06	6.61e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—PIK3CD—melanoma	3.14e-06	6.57e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—ALB—melanoma	3.1e-06	6.48e-05	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—PTEN—melanoma	3.04e-06	6.35e-05	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—PTEN—melanoma	2.79e-06	5.84e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—PTEN—melanoma	2.77e-06	5.79e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—PIK3CG—melanoma	2.76e-06	5.77e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—PIK3CB—melanoma	2.74e-06	5.73e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—PTGS2—melanoma	2.71e-06	5.67e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—PPARG—melanoma	2.66e-06	5.57e-05	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—PIK3CA—melanoma	2.62e-06	5.47e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—PIK3CD—melanoma	2.43e-06	5.07e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—ALB—melanoma	2.39e-06	5e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—PTEN—melanoma	2.37e-06	4.95e-05	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—PIK3CA—melanoma	2.14e-06	4.48e-05	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—AKT1—melanoma	2.14e-06	4.47e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—PIK3CB—melanoma	2.11e-06	4.42e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—PTGS2—melanoma	2.1e-06	4.38e-05	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—PIK3CA—melanoma	1.97e-06	4.12e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—PIK3CA—melanoma	1.95e-06	4.08e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—PTEN—melanoma	1.83e-06	3.82e-05	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—AKT1—melanoma	1.75e-06	3.66e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—PIK3CA—melanoma	1.67e-06	3.49e-05	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—AKT1—melanoma	1.61e-06	3.37e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—AKT1—melanoma	1.6e-06	3.34e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—AKT1—melanoma	1.36e-06	2.85e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—PIK3CA—melanoma	1.29e-06	2.69e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—AKT1—melanoma	1.05e-06	2.2e-05	CbGpPWpGaD
